The U.S. House of Representatives has passed a bill aimed at restricting business with several Chinese biotech companies, including WuXi AppTec and BGI, citing national security concerns. Other companies named are China's MGI and its California-based subsidiary Complete Genomics. The Biosecure Act, which passed with a significant majority of 306...
Biospace: U.S.’s BIOSECURE Act Will Open Opportunities for India’s CDMOs
A new article by Tyler Patchen writing for Biospace highlight how the BIOSECURE Act, a U.S. House bill that aims to restrict American biopharma companies from working with certain Chinese contract development and manufacturing organizations (CDMOs), particularly WuXi AppTec and WuXi Biologics will impact biopharma companies in the U.S. The...